Stryker (SYK) Stock Forecast & Price Target

Stryker is well-positioned for sustained growth with its high-quality product portfolio, strong leadership position in operating room equipment, and increasing revenue exposure to higher-growth end markets through organic and inorganic investments. Its systematic commercial organization and consistently successful execution in translating product innovations into share gains have proven its category dominance, resulting in above-market growth. Despite the potential risks of increasing competition in orthopedic robotics and slower-than-expected adoption in the ambulatory surgical center (ASC) setting, Stryker's strong management, solid operating margins, and potential for further acquisitions and end-market expansion make it a top pick in the large cap MedTech space.

Stryker is facing multiple headwinds, including slower than expected adoption of new products in the ASC setting and a potential slowdown in market growth. In addition, the company's recent cyberattack resulted in a material impact on 1Q26 results, and while management expects to recuperate most of the lost sales in the second half of the year, there is a risk that this may not materialize. Competition in the orthopedic robotics space is also increasing, which could lead to market share loss and pressure on margins.